Results 41 to 50 of about 28,885 (301)

RELEASE OF HISTAMINE BY H2-RECEPTOR ANTAGONISTS [PDF]

open access: yesThe Lancet, 1982
letter
Parkin, J. V.   +4 more
openaire   +3 more sources

Versatile Detection of Cellular Protein via Fluorescence Anisotropy

open access: yesAdvanced Science, EarlyView.
Cell Lysate Fluorescence Anisotropy (CFAST) utilizes long lifetime dye‐labeled nanobodies for rapid protein quantification in minimally purified, complex cell lysate. When coupled with cellular thermal shift, CFAST allows high‐throughput detection of endogenous protein‐small molecule engagement, facilitating the discovery of novel binders for ...
Qing Tang   +12 more
wiley   +1 more source

Anti-KSHV activity of antagonists of histamine receptors. [PDF]

open access: yes, 2019
Anti-KSHV activity of antagonists of histamine receptors.
Lu Dai (528895)   +8 more
core   +1 more source

Histamine release and fibrinogen adsorption mediate acute inflammatory responses to biomaterial implants in humans

open access: yesJournal of Translational Medicine, 2007
Background Medical implants often fail as a result of so-called foreign body reactions during which inflammatory cells are recruited to implant surfaces.
Eaton John W   +2 more
doaj   +1 more source

Nanomaterials for Allergy Diagnosis and Treatment: Advances, Opportunities and Translational Challenges

open access: yesAdvanced Science, EarlyView.
Nanomaterials offer dual applications in allergy management. For diagnosis, nanomaterials enhance analytical sensitivity and improve detection in specific IgE and functional assays such as the basophil activation test (BAT). For allergen‐specific immunotherapy, nanomaterials enable allergen masking and controlled release, and effectively modulate the ...
Madiha Habib   +8 more
wiley   +1 more source

Novel Insight of Histamine and Its Receptor Ligands in Glaucoma and Retina Neuroprotection

open access: yesBiomolecules, 2021
Glaucoma is a multifactorial neuropathy characterized by increased intraocular pressure (IOP), and it is the second leading cause of blindness worldwide after cataracts.
Silvia Sgambellone   +3 more
doaj   +1 more source

Mucoadhesive Peptide‐Catalase Self‐Assembled Nano‐Formulation for Effective Treatment of Mucosal Inflammatory Diseases

open access: yesAdvanced Science, EarlyView.
CR8L10 is self‐assembled with catalase (CAT) to form CR8L10@CAT nanocomplexes, which can anchor to mucosal surfaces via thiol‐disulfide exchange with mucin, thereby enhancing their mucosal retention. The efficient reactive oxygen species (ROS) scavenging at inflamed sites would then result in successful treatment in both the intravesical IC/BPS model ...
Xinzhu Li   +13 more
wiley   +1 more source

Potential immunological consequences of pharmacological suppression of gastric acid production in patients with multiple sclerosis

open access: yesBMC Medicine, 2012
Corticosteroids are standard treatment for patients with multiple sclerosis experiencing acute relapse. Because dyspeptic pain is a common side effect of this intervention, patients can be given a histamine receptor-2 antagonist, proton pump inhibitor or
Biswas Sangita   +3 more
doaj   +1 more source

Targeted β‐Glucan‐Veiled Oral Apremilast Nanotherapy Modulates Key Dysbiosis‐Associated Gut Microbiota and Alleviates Ulcerative Colitis‐Associated Anxiety, Depression, and Neuropsychiatric Behaviors

open access: yesAdvanced Science, EarlyView.
This study introduces β‐glucan‐shielded apremilast laden nanomicelles that withstand gastrointestinal degradation, selectively accumulate in inflamed colon tissue, and modulate the microbiota–gut–brain axis. The formulation restores barrier integrity, reduces systemic and neuroinflammation, and improves anxiety‐ and depression‐like behaviors in colitis
Chandrashekhar Jori   +10 more
wiley   +1 more source

Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists [PDF]

open access: yes, 2003
In the present study we searched for neutral antagonists for the human histamine
Smit, Martine J.   +19 more
core   +1 more source

Home - About - Disclaimer - Privacy